Medeon Biodesign Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	303.82	520.79	513.37	1,238	483.9	735.32
Short-Term Investments	719.23	656.96	652.18	862.1	1,025	1,608
Trading Asset Securities	40.65	42.12	41.66	41.93	37.87	6.48
Cash & Short-Term Investments	1,064	1,220	1,207	2,142	1,547	2,350
Cash Growth	9.10%	1.05%	-43.64%	38.44%	-34.16%	7.49%
Accounts Receivable	45.7	39.26	37.84	41.77	32.35	10.12
Other Receivables	11.4	7.17	7.71	8.37	26.65	5.12
Receivables	57.1	46.43	45.55	50.15	59.01	15.25
Inventory	28.02	24.84	34.1	10.77	10.06	-
Prepaid Expenses	30.02	-	-	24.89	21.42	24.68
Other Current Assets	3.19	31.02	30.34	-	-	-
Total Current Assets	1,182	1,322	1,317	2,228	1,638	2,390
Property, Plant & Equipment	306.94	267.83	355.47	321.82	340.24	44.52
Long-Term Investments	-	-	-	-	1,876	1,847
Goodwill	106.74	106.74	106.74	106.74	106.74	39.23
Other Intangible Assets	42.91	45.36	55.01	64.33	73.44	39.71
Long-Term Deferred Tax Assets	32.95	32.95	32.95	-	-	-
Other Long-Term Assets	7.85	4.77	10.37	26.46	5.59	4.58
Total Assets	1,679	1,780	1,878	2,747	4,040	4,364
Accounts Payable	9.38	7.55	12	5.36	3.94	0.05
Accrued Expenses	67.62	85.37	113.03	98.01	73.09	68.33
Current Portion of Leases	45.59	41.39	54.56	47.15	36.69	14.53
Current Income Taxes Payable	-	-	-	37.97	56.78	66.74
Current Unearned Revenue	4.97	7.94	4.51	3.11	0.86	0.65
Other Current Liabilities	16.42	18.7	31.54	30.16	27.17	10
Total Current Liabilities	143.98	160.96	215.64	221.76	198.51	160.3
Long-Term Leases	117.17	71.66	113.84	139.59	162.22	15.71
Long-Term Deferred Tax Liabilities	9.93	10.41	12.36	14.31	15.74	-
Total Liabilities	271.08	243.03	341.84	375.65	376.48	176
Common Stock	969.45	969.45	922.45	922.45	878.4	732.34
Additional Paid-In Capital	1,959	-	-	1,341	1,344	1,349
Retained Earnings	-1,618	-1,496	-792.94	31.25	1,355	2,072
Treasury Stock	-	-	-5.25	-10.6	-10.6	-10.6
Comprehensive Income & Other	47.96	2,002	1,396	36.18	30.94	-12.49
Total Common Equity	1,358	1,476	1,520	2,320	3,597	4,130
Minority Interest	50.17	61.03	15.71	51.51	66.1	58.15
Shareholders' Equity	1,408	1,537	1,536	2,371	3,664	4,188
Total Liabilities & Equity	1,679	1,780	1,878	2,747	4,040	4,364
Total Debt	162.77	113.05	168.4	186.74	198.91	30.24
Net Cash (Debt)	900.94	1,107	1,039	1,955	1,348	2,320
Net Cash Growth	10.03%	6.55%	-46.87%	45.01%	-41.87%	36.98%
Net Cash Per Share	9.64	11.99	11.27	21.24	14.65	25.19
Filing Date Shares Outstanding	96.71	96.94	92.14	92.04	92.02	92.02
Total Common Shares Outstanding	96.71	96.94	92.14	92.04	92.02	92.02
Working Capital	1,038	1,161	1,102	2,006	1,439	2,230
Book Value Per Share	14.04	15.22	16.50	25.21	39.10	44.89
Tangible Book Value	1,209	1,324	1,358	2,149	3,417	4,051
Tangible Book Value Per Share	12.50	13.65	14.74	23.35	37.14	44.03
Machinery	218.52	220.85	229.55	178.49	168.97	46.34
Leasehold Improvements	100.88	100.5	84.96	46.22	45.6	6.43